General information

Clomiphene is a very weak non-steroidal estrogen; it blocks the feedback effect of endogenous estrogens on the pituitary, promoting the further secretion of gonadotropins. The primary use of clomiphene in women is in the induction of ovulation. In men, it has been used to treat infertility in view of its ability to increase endogenous production of testosterone [ ].

Drug studies

In one large study, some adverse reactions in treated women were due to its ovulatory effects and others were direct reactions to the substance itself [ ]. The most common problem was ovarian enlargement (14%), followed by hot flushes (11%), abdominal and pelvic discomfort (7.0%), and nausea and vomiting (2.1%). Incidental symptoms were breast discomfort, vaginal changes, psychological symptoms, headache, heavier menses, and increased urinary frequency. Sporadic case-reports on clomiphene in the literature relate to fetal ovarian dysplasia or maternal psychosis [ ], either of which may have been coincidental. However, it must be borne in mind that the substance is related structurally to triparanol, an obsolete drug that produced a series of disastrous adverse effects some 40 years ago.

In another study, the adverse effects of the antiestrogenic effects of clomiphene citrate were hot flushes (10%), mood swings, depression, headaches (1%), pelvic pain (5.5%), nausea (2%), breast tenderness (2–5%), dryness and loss of hair (0.3%), visual symptoms, halos and streaks around lights (particularly at night), blurring, and scotoma (1.5%) [ ].

Organs and systems

Cardiovascular

A 33-year-old woman who had used clomiphene citrate had an anterolateral myocardial infarction when pregnant at 5 weeks; a subsequent exercise stress test and coronary angiography were normal [ ].

Central retinal vein occlusion occurred in a 36-year-old woman who took eight courses of clomiphene citrate [ ].

Nervous system

In a multicenter WHO study, two men withdrew because of visual disturbances, dizziness, and headaches [ ].

Sensory systems

Bilateral anterior uveitis occurred during the use of clomiphene citrate in a 30-year-old woman with polycystic ovary syndrome; rechallenge with clomiphene 3 months later resulted in recurrence [ ].

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here